We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Kadant
KAI
$3.94B
| $34.5M | 0.13% |
100,079
-10,700
| -10% | -$3.88M |
|
152
Regeneron Pharmaceuticals
REGN
$83B
| $34.3M | 0.13% |
48,154
-35,486
| -42% | -$29.8M |
|
153
ReposiTrak
TRAK
$151M
| $33.7M | 0.13% |
1,524,348
+169,348
| +12% | +$3.59M |
|
154
PayPal
PYPL
$51.3B
| $33.7M | 0.13% |
395,145
+46,380
| +13% | +$3.9M |
|
155
Simon Property Group
SPG
$72.1B
| $33.6M | 0.13% |
194,846
+44,141
| +29% | +$7.75M |
|
156
McKesson
MCK
$101B
| $33M | 0.13% |
57,948
+8,304
| +17% | +$4.65M |
|
157
Kinsale Capital Group
KNSL
$8.62B
| $32.9M | 0.13% |
70,700
+64,900
| +1,119% | +$30.7M |
|
158
Darling Ingredients
DAR
$9.98B
| $32.5M | 0.12% |
964,622
-239,401
| -20% | -$9.05M |
|
159
Zoetis
ZTS
$30.5B
| $32.1M | 0.12% |
197,168
-13,271
| -6% | -$2.37M |
|
160
Copart
CPRT
$27.3B
| $32M | 0.12% |
557,126
+97,875
| +21% | +$5.57M |
|
161
CrowdStrike
CRWD
$229B
| $31.3M | 0.12% |
365,764
+56,772
| +18% | +$4.72M |
|
162
3M
MMM
$94.2B
| $31M | 0.12% |
239,848
-9,678
| -4% | -$1.27M |
|
163
CME Group
CME
$95.1B
| $30.9M | 0.12% |
133,087
+6,451
| +5% | +$1.48M |
|
164
Norfolk Southern
NSC
$76.2B
| $30.6M | 0.12% |
130,541
+33,460
| +34% | +$8.51M |
|
165
Ameresco
AMRC
$1.48B
| $30.4M | 0.12% |
1,293,914
-382,588
| -23% | -$11.1M |
|
166
Ecolab
ECL
$78B
| $29.9M | 0.11% |
127,472
+5,506
| +5% | +$1.37M |
|
167
BlackLine
BL
$1.68B
| $29.7M | 0.11% |
489,200
+84,800
| +21% | +$5.06M |
|
168
nVent Electric
NVT
$27.5B
| $29.7M | 0.11% |
435,924
-172,555
| -28% | -$12.7M |
|
169
Moody's
MCO
$83.5B
| $29.3M | 0.11% |
61,953
+9,830
| +19% | +$4.69M |
|
170
Colgate-Palmolive
CL
$74.5B
| $29.3M | 0.11% |
322,322
-10,650
| -3% | -$1.02M |
|
171
Digital Realty Trust
DLR
$73.4B
| $29.2M | 0.11% |
164,917
+18,277
| +12% | +$3.24M |
|
172
AutoZone
AZO
$50.5B
| $29.1M | 0.11% |
9,091
-180
| -2% | -$570K |
|
173
Jabil
JBL
$38.9B
| $28.5M | 0.11% |
198,348
+165,900
| +511% | +$21.8M |
|
174
Royal Caribbean
RCL
$83.2B
| $28.4M | 0.11% |
123,121
-7,991
| -6% | -$1.77M |
|
175
Gates Industrial Corporation Ltd.
GTES
$7B
| $28.2M | 0.11% |
1,372,300
+129,700
| +10% | +$2.62M |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.